New Treatment for Locally Advanced Form of Most Common Skin Cancer
Last week, the U.S. Food and Drug Administration (FDA) approved a new anticancer therapeutic called sonidegib (Odomzo) for patients...
Tag: FDA
Last week, the U.S. Food and Drug Administration (FDA) approved a new anticancer therapeutic called sonidegib (Odomzo) for patients...
This year may indeed be the year in which a class of immunotherapeutics called PD-1 and PD-L1 inhibitors are...
Immunotherapeutics called PD-1 inhibitors have garnered a lot of attention in the past year thanks to exciting clinical trial...
There has been a series of immunotherapy approvals since the end of last year, and following this trend, on...
The field of cancer immunotherapy broke new ground last week when the U.S. Food and Drug Administration (FDA) announced...
Just days before the start of multiple myeloma awareness month, which began Sunday, March 1, the U.S. Food and...
Yet more good news emanated from the U. S. Food and Drug Administration (FDA) last week when it announced...
The rapid fire of U.S. Food and Drug Administration (FDA) approvals of new treatments for cancer continued last week...
Last week, the U.S. Food and Drug Administration (FDA) announced the first-ever approval of a treatment for Waldenström macroglobulinemia,...
Cancer immunotherapy, which entered 2014 with the accolade of Science magazine’s Breakthrough of the Year for 2013, ended the...